Lawrence David Wagman MD
Breast, Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Clinical Professor of Surgery, Department Surgery, City of Hope, Regional Medical Director, Inland Empire and South Bay
Join to View Full Profile
1100 San Bernardino Road Suite 1100Upland, CA 91786
Phone+1 909-949-2242
Fax+1 909-981-5783
Dr. Wagman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lawrence Wagman is a surgical oncologist in Upland and Duarte, CA and is affiliated with multiple hospitals in the area, including City of Hope's Helford Clinical Research Hospital, St. Joseph Hospital Orange, and San Antonio Regional Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 39 years. He specializes in breast, hepatobiliary surgery, pancreas, and surgical oncology (other than breast) and is experienced in minimally invasive surgery, breast surgery, surgical oncology (non-breast), and clinical research.
Education & Training
Virginia Commonwealth University Health SystemResidency, Surgery, 1982 - 1985- Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1978 - 1985
National Cancer Institute, Surgery BranchMD, Tumor Metabolism, 1980 - 1982
Columbia University Vagelos College of Physicians and SurgeonsClass of 1978
Certifications & Licensure
CA State Medical License 1985 - 2027
MD State Medical License 1985 - 2021
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:LA Area Castle Connolly, 2013
Clinical Trials
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® Start of enrollment: 2009 Feb 01
- Microwave Ablation of Breast Tumors Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 2 citationsReduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.Kevin P Labadie, Darrell Fan, Dana A Dominguez, Paul Wong, Elizabeth Meshkin
Annals of Surgical Oncology. 2025-12-01 - ASO Visual Abstract: Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.Kevin P Labadie, Darrell Fan, Dana Dominguez, Paul Wong, Elizabeth Meshkin
Annals of Surgical Oncology. 2025-07-31 - NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab.Lawrence D Wagman, David A Geller, Samuel A Jacobs, Nicholas J Petrelli, Carmen J Allegra
Journal of Surgical Oncology. 2022-12-01
Press Mentions
Hurricanes, Fires, Floods: A Rising Threat to Cancer CareMay 20th, 2025![Examples of Surgical Procedures [4.4]](https://doximity-res.cloudinary.com/image/upload/v1/ingestion_media/r1gqs2n35jfcmnfxve0w.png)
Examples of Surgical Procedures [4.4]May 2nd, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
